Lonza to Acquire a US Clinical Manufacturing Site to Support Ongoing Customer Demand
Lonza announced today that it is acquiring a clinical-stage mammalian manufacturing site in the United States from Shire plc.
October 3, 2017
1 Min Read
Lonza announced today that it is acquiring a clinical-stage mammalian manufacturing site in the United States from Shire plc.
Subscribe for the latest consumer trends, trade news, nutrition science and regulatory updates in the supplement industry!
Join 37,000+ members. Yes, it's completely free.
You May Also Like